1-BENZOYL-2-(2-NITROPHENYL)-1H-BENZIMIDAZOLE DERIVATIVES: A NOVEL APPROACH TO THE DEVELOPMENT OF NEW HIV-1 REVERSE TRANSCRIPTASE INHIBITORS

作者: David Vásquez , Carlos F Lagos , Jaime Mella-Raipán , Luis González , Roberto Ebensperger

DOI: 10.4067/S0717-97072007000400002

关键词: Reverse transcriptaseMolecular modelStereochemistryMoietyBenzimidazoleBiological activityEnzymeIn vitroSubstituentChemistry

摘要: A novel approach to the development of a new class HIV-1 RT inhibitors is reported. The 1-benzoyl-2-aryl-1H-benzimidazole series was designed as combination two previously reported active scaffolds, benzimidazole and benzoyl moieties. compounds effectively blocked reverse transcription in micromolar range an vitro assay containing wild-type enzyme. We have demonstrated that 2-nitrophenyl C-2 substituent important structural feature for desired biological activity this series. Molecular docking experiments suggest adopt butterflylike conformation within binding pocket enzyme, with moiety located extended hydrophobic region defined mainly by Tyrl 81, 88, Trp229

参考文章(27)
Frits Daeyaert, Marc de Jonge, Jan Heeres, Luc Koymans, Paul Lewi, Maarten H. Vinkers, Paul A.J. Janssen, A pharmacophore docking algorithm and its application to the cross‐docking of 18 HIV‐NNRTI's in their binding pockets Proteins. ,vol. 54, pp. 526- 533 ,(2004) , 10.1002/PROT.10599
Karen R. Romines, George A. Freeman, Lee T. Schaller, Jill R. Cowan, Steve S. Gonzales, Jeffrey H. Tidwell, Clarence W. Andrews, David K. Stammers, Richard J. Hazen, Robert G. Ferris, Steven A. Short, Joseph H. Chan, Lawrence R. Boone, Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitor. Journal of Medicinal Chemistry. ,vol. 49, pp. 727- 739 ,(2006) , 10.1021/JM050670L
Marilyn B Kroeger Smith, Stephen H Hughes, Paul L Boyer, Christopher J Michejda, Carol A Rouzer, Lisa A Taneyhill, Richard H Smith Jr, Nathan A Smith, Paul AJ Janssen, Henri Moereels, Luc Koymans, Edward Arnold, Jianping Ding, Kalyan Das, Wanyi Zhang, None, Molecular modeling studies of HIV-1 reverse transcriptase nonnucleoside inhibitors: total energy of complexation as a predictor of drug placement and activity. Protein Science. ,vol. 4, pp. 2203- 2222 ,(1995) , 10.1002/PRO.5560041026
Jianping Ding, Kalyan Das, Henri Moereels, Luc Koymans, Koen Andries, Paul A.J. Janssen, Stepen H. Hughes, Edward Arnold, Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors Nature Structural & Molecular Biology. ,vol. 2, pp. 407- 415 ,(1995) , 10.1038/NSB0595-407
Rino Ragno, Marino Artico, Gabriella De Martino, Giuseppe La Regina, Antonio Coluccia, Alessandra Di Pasquali, Romano Silvestri, Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives. Journal of Medicinal Chemistry. ,vol. 48, pp. 213- 223 ,(2005) , 10.1021/JM040854K
Erik De Clercq, Antiviral drugs in current clinical use. Journal of Clinical Virology. ,vol. 30, pp. 115- 133 ,(2004) , 10.1016/J.JCV.2004.02.009
Maria Letizia Barreca, Angela Rao, Laura De Luca, Maria Zappalà, Anna-Maria Monforte, Giovanni Maga, Christophe Pannecouque, Jan Balzarini, Erik De Clercq, Alba Chimirri, Pietro Monforte, Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT. Journal of Medicinal Chemistry. ,vol. 48, pp. 3433- 3437 ,(2005) , 10.1021/JM049279A
Bahram Hemmateenejad, S. Mohammad Hossein Tabaei, Fatemeh Namvaran, Computer-aided design of potential anti-HIV-1 non-nucleoside reverse transcriptase inhibitors by contraction of β-ring in TIBO derivatives Journal of Molecular Structure-theochem. ,vol. 732, pp. 39- 45 ,(2005) , 10.1016/J.THEOCHEM.2005.07.015